NCT06243575

Comparison of Outcomes Between Intraosseous Femoral and Tibial Injection in Simultaneous Bilateral Total Knee Arthroplasty Patients

Comparison of Outcomes Between Multimodal Intraosseous Femoral Injection and Multimodal Intraosseous Tibial Injection, A Randomized Controlled Trial in Simultaneous Bilateral Total Knee Arthroplasty Patients
Rajavithi Hospital·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Pain, Postoperative
Drug/Device/Intervention
Multimodal Intraosseous Femoral Injection
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Rajavithi Hospital
Location
Phaya Thai, Thailand
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2024
End date
Apr 30, 2024
Enrollment
20 participants
Primary outcome

Pain score (Visual analog scale)

Summary

In patients with osteoarthritis of the knee whose pain cannot be relieved by conservative
 treatment, total knee arthroplasty (TKA) is the operation that increases the quality of life
 for the patient. Pain management after total knee arthroplasty TKA is an important
 consideration to improve patient outcomes and reduce length of stay. Periarticular injections
 of the knee are one of the techniques used to reduce pain after surgery. Studies have shown
 that compared to other methods of pain relief, they are effective and safe. At present, no
 studies to compare between multimodal intraosseous femoral injection & multimodal
 intraosseous tibial injection in Simultaneous Bilateral TKA patients.

ICD-10 classifications
During surgical operationDuring surgical operationDuring surgical operationPain, unspecifiedPostoperative intestinal obstruction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06243575
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06243575 through Pure Global AI's free database. This phase not specified trial is sponsored by Rajavithi Hospital and is currently Recruiting. The study focuses on Pain, Postoperative. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.